VivoSeq
Other

Adolescent

0

Pipeline Programs↗

37

Active Trials↗

52

Companies Involved↗

Adolescent is an early-stage landscape with 0 programs across 52 companies. The most active players are Sanofi, Pfizer, Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalEli Lilly logo

Eli Lilly

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

288

clinical trials

Completed204 · 71%
Recruiting21 · 7%
Unknown status16 · 6%
Terminated16 · 6%
Withdrawn14 · 5%
Active, not recruiting12 · 4%
Other5 · 2%

Clinical Trials

Trial Activity

288 trials

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Recruiting·IIovance Biotherapeutics, Inc.·Phase 1·NCT06566092·40 enrolled
Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
Recruiting·Sinovac Biotech Co., Ltd logoSinovac Biotech Co., Ltd·Phase 4·NCT07354269·180 enrolled
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
Recruiting·UUniversity of Colorado, Denver·Phase 3·NCT05935826·55 enrolled
A Phase 2/3 Study in Adult and Adolescent Participants With SCD
Recruiting·Pfizer logoPfizer·Phase 2/3·NCT05431088·389 enrolled
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Recruiting·VVanda Pharmaceuticals·Phase 4·NCT05648591·100 enrolled
CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
Recruiting·SShanghai Jiao Tong University School of Medicine·Phase 1·NCT07371767·15 enrolled
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Recruiting·Gilead logoGilead·Phase 2/3·NCT06532656·75 enrolled
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Recruiting·Children's Oncology Group·Phase 3·NCT06513962·60 enrolled
Probiotic Administration for Adolescent Depression
Recruiting·UUniversity of California, San Francisco·Phase 1·NCT06898788·77 enrolled
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Recruiting·CCUTISS AG·Phase 3·NCT06745557·70 enrolled
Development and Application of Comprehensive Intervention Techniques for Adolescent Depression
Recruiting·FFirst Affiliated Hospital of Zhejiang University·N/A·NCT05945342·100 enrolled
Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD
Recruiting·SShanghai Mental Health Center·N/A·NCT06942494·88 enrolled
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
Recruiting·Gilead logoGilead·Phase 4·NCT06337032·350 enrolled
IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
Recruiting·SShanghai Mabgeek Biotech.Co.Ltd·Phase 1/2·NCT06765005·24 enrolled
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Recruiting·Gilead logoGilead·Phase 2·NCT06749054·12 enrolled
Page 1 of 20

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)